Patent details

EP2474321 Title: Compositions suitable for treating collagen-mediated diseases

Basic Information

Publication number:
EP2474321
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP121552335
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Compositions suitable for treating collagen-mediated diseases
French Title of Invention:
Compositions de traitement des maladies mediees par le collagene
German Title of Invention:
Zusammensetzungen zur Behandlung collagenbedingter Erkrankungen
SPC Number:

Dates

Filing date:
30/01/2007
Grant date:
17/04/2019
EP Publication Date:
11/07/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2019
EP B1 Publication Date:
17/04/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/01/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/04/2019
 
 

Name:
BioSpecifics Technologies Corp.
Address:
35 Wilbur Street, Lynbrook, NY 11563, United States (US)

Name:
Endo Global Ventures
Address:
22 Victoria Street, Canon's Court, Hamilton HM12, Bermuda (BM)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
02/05/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Bassett, Philip J.
Address:
United Kingdom (GB)

2

Name:
Tharia, Hazel A.
Address:
United Kingdom (GB)

3

Name:
Sabatino, Gregory L.
Address:
United States (US)

4

Name:
Hitchcock, Antony G.
Address:
United Kingdom (GB)

5

Name:
Del Tito, Jr., Benjamin J.
Address:
United States (US)

Priority

1

Priority Number:
763470 P
Priority Date:
30/01/2006
Priority Country:
United States (US)

2

Priority Number:
784135 P
Priority Date:
20/03/2006
Priority Country:
United States (US)

3

Priority Number:
699302
Priority Date:
29/01/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/48; C12N 9/52;

Publication

European Patent Bulletin

Issue number:
201916
Publication date:
17/04/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
20
Annual Fee Amount:
300 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/12/2024
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
02/05/2019 Power Of Attorney 1
14/05/2019 Outgoing Correspondence 1